MedPath
TGA Approval

ZolaCos CP combination Goserelin 10.8mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack (125687)

125687

ZolaCos CP combination Goserelin 10.8mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack

AstraZeneca Pty Ltd

December 1, 2006

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/1441b0f647b010f95a59e5d6abebc024.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/d6e5f240bc020cf2cf98d62e62b13039.pdf

Active Ingredients

bicalutamide

goserelin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZolaCos CP combination Goserelin 10.8mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack (125687) - TGA 批准文号 | MedPath